These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 15689599)

  • 1. Resistance to thyroid hormone in Hashimoto's thyroiditis.
    Fukata S; Brent GA; Sugawara M
    N Engl J Med; 2005 Feb; 352(5):517-8. PubMed ID: 15689599
    [No Abstract]   [Full Text] [Related]  

  • 2. Episodes of thyrotoxicosis in Hashimoto's thyroiditis.
    Gonzalez Gonzalez A; Recio Cordov JM; Rodriguez-García JL; Velasco Romero AM; Rubio Herrera MA
    Minerva Endocrinol; 2010 Mar; 35(1):35-6. PubMed ID: 20386526
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of hypothyroidism caused by Hashimoto's thyroiditis.
    Comtois R; Faucher L; Laflèche L
    Arch Intern Med; 1995 Jul; 155(13):1404-8. PubMed ID: 7794089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of thyroid hormone treatment on thyromegaly in children and adolescents with Hashimoto disease.
    Rother KI; Zimmerman D; Schwenk WF
    J Pediatr; 1994 Apr; 124(4):599-601. PubMed ID: 8151477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of iodine and thyroid hormones in the induction and therapy of Hashimoto's thyroiditis].
    Rink T; Schroth HJ; Holle LH; Garth H
    Nuklearmedizin; 1999; 38(5):144-9. PubMed ID: 10488481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic levothyroxine therapy in patients with Hashimoto's thyroiditis.
    Schumm-Draeger PM; Padberg S; Heller K
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S84-7. PubMed ID: 10522812
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance to thyroid hormone associated with autoimmune thyroid disease in a Turkish family.
    Aksoy DY; Gurlek A; Ringkananont U; Weiss RE; Refetoff S
    J Endocrinol Invest; 2005 Apr; 28(4):379-83. PubMed ID: 15966514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hashimoto's disease in Turner's syndrome.
    Fleming S; Cowell C; Bailey J; Burrow GN
    Clin Invest Med; 1988 Aug; 11(4):243-6. PubMed ID: 3168347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of the antigliadin antibodies in autoimmune thyroid diseases.
    Akçay MN; Akçay G
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():cclxxix-cclxxx. PubMed ID: 15244201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid hormone autoantibodies in Hashimoto's thyroiditis: often transient but also increasingly frequent.
    Benvenga S; Trimarchi F
    Thyroid; 2003 Oct; 13(10):995-6; author reply 996. PubMed ID: 14611712
    [No Abstract]   [Full Text] [Related]  

  • 12. Spontaneous remission of hypothyroidism in Hashimoto's (autoimmune) thyroiditis.
    Sasaki H; Eimoto T; Yamamoto T; Asano T; Okamura M
    Isr J Med Sci; 1984 Jul; 20(7):625-9. PubMed ID: 6547931
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dosage of thyroid hormone in substitution therapy].
    Wiklund B
    Lakartidningen; 2001 Nov; 98(48):5554. PubMed ID: 11769377
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin].
    Aiello A; Cristofaro M; Carrozza F; Di Rienzo G; Carile L
    Clin Ter; 1990 May; 133(4):227-31. PubMed ID: 2142910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 levels in patients with disorders of the thyroid gland.
    Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hashimoto's thyroiditis presenting as bilateral knee arthropathy.
    Gillan MM; Scofield RH; Harley JB
    J Okla State Med Assoc; 2002 May; 95(5):323-5. PubMed ID: 12043105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epilepsy, disturbances of behavior and consciousness in presence of normal thyroxine levels: still, consider the thyroid gland].
    Vrancken AF; Braun KP; de Valk HW; Rinkel GJ
    Ned Tijdschr Geneeskd; 2000 Jan; 144(1):5-8. PubMed ID: 10665296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hashimoto's encephalopathy: toxic or autoimmune mechanism?].
    Ghawche F; Bordet R; Destée A
    Rev Neurol (Paris); 1992; 148(5):371-3. PubMed ID: 1448653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.